uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Anticancer agent CHS 828 suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity.
Show others and affiliations
2004 (English)In: Int J Cancer, ISSN 0020-7136, Vol. 111, no 2, 198-205 p.Article in journal (Other scientific) Published
Place, publisher, year, edition, pages
2004. Vol. 111, no 2, 198-205 p.
Keyword [en]
Animals, Apoptosis/*drug effects, Carcinoma; Non-Small-Cell Lung, Carcinoma; Small Cell/pathology, Cell Division, Cyanides/*pharmacology, Down-Regulation, Female, Guanidines/*pharmacology, Humans, Lung Neoplasms/pathology, Mice, NF-kappa B/*metabolism/pharmacology, Protein-Serine-Threonine Kinases/*pharmacology, Transplantation; Heterologous, Tumor Cells; Cultured
Identifiers
URN: urn:nbn:se:uu:diva-71895PubMedID: 15197771OAI: oai:DiVA.org:uu-71895DiVA: diva2:99806
Available from: 2007-02-09 Created: 2007-02-09 Last updated: 2011-01-12

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15197771&dopt=Citation

Authority records BETA

Larsson, Rolf

Search in DiVA

By author/editor
Larsson, Rolf
By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 356 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf